A challenging case of aggressive composite hemangioendothelioma with neuroendocrine differentiation and <i>PTBP1::MAML2</i> fusion-Reference-Cited by-同舟云学术

A challenging case of aggressive composite hemangioendothelioma with neuroendocrine differentiation and PTBP1::MAML2 fusion

Published:2024-06 Issue:6 Volume:63 Page:
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosomes & Cancer

Author:

Bontoux Christophe¹²³⁴^ORCID,Vigier Anna¹²,Valentin Thibaud³⁵,Syrykh Charlotte¹²^ORCID,Siegfried Aurore¹²,Basset Céline¹²,Mourlanette Jean²⁶,Reboul Hadrien¹²,Evrard Solène¹²,Gomez‐Mascard Anne¹²³⁴

Affiliation:

1. Department of Pathology Cancer University Institute of Toulouse‐Oncopole, University Hospital of Toulouse Toulouse France

2. University of Toulouse III Paul Sabatier Toulouse France

3. OncoSarc, INSERM U1037, Cancer Research Center in Toulouse Toulouse France

4. Cancer Biobank, Cancer University Institute of Toulouse‐Oncopole Toulouse France

5. Department of Medical Oncology Cancer University Institute of Toulouse‐Oncopole Toulouse France

6. Thoracic Oncology Department Larrey Hospital, University Hospital of Toulouse Toulouse France

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/gcc.23245

Reference5 articles.

1. Recurrent PTBP1::MAML2 fusions in composite hemangioendothelioma with neuroendocrine differentiation: A report of two cases involving neck lymph nodes

2. Composite hemangioendothelioma with neuroendocrine marker expression: an aggressive variant

3. Recurrent YAP1 and MAML2 Gene Rearrangements in Retiform and Composite Hemangioendothelioma

4. NovelYAP1-TFE3fusion defines a distinct subset of epithelioid hemangioendothelioma

5. Immunohistochemistry for TFE3 lacks specificity and sensitivity in the diagnosis of TFE3-rearranged neoplasms: a comparative, 2-laboratory study